Arsenale Bioyards key facts
as of Oct 2026- Developer of an end-to-end hardware and software platform intended for bio-manufacturing.
- Arsenale Bioyards is valued at approximately $14.0M as of Oct 2026 (last reported valuation).
- It has raised $24.7M; the latest was Seed Round ($10.4M) in Feb 2025.
- Notable investors include Plug and Play Tech Center, CDP Venture Capital (Rome), Acequia Capital, byFounders, Planet A — 9 tracked in total.
- Status: Privately Held (backing).
Arsenale Bioyards's last reported valuation, Nov 2023. Nothing priced has surfaced since.
- ·Watch Arsenale Bioyards: the Monday email on marks, rounds and moves
Arsenale Bioyards funding rounds
No funding rounds for Arsenale Bioyards are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Arsenale Bioyards valuation
Arsenale Bioyards's last reported valuation was $14 million in Nov 2023. No priced round, secondary trade or fund mark has surfaced since.
Arsenale Bioyards investors
9 investors are on record for Arsenale Bioyards, including Plug and Play Tech Center, CDP Venture Capital (Rome), Acequia Capital and byFounders.
About Arsenale Bioyards
Developer of an end-to-end hardware and software platform intended for bio-manufacturing. The company's platform spans various stages of the biomanufacturing process, ranging from lab to manufacturing scale, to allow scalable, low-cost production through nature co-design, enabling firms to reduce cost, time-to-market, and risks in creating bio-based products.
- Sector
- Healthcare
- HQ
- Venice, Italy
- Founded
- 2022
- Employees
- 33
- Website
- arsenale.bio/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.